Wegovy is a glucagon-like peptide-1 (GLP-1) receptor agonist manufactured by Novo Nordisk that is approved by the U.S. Food ...

Weight-loss injections are dominating the market: Where will GLP-1 pills fit in? Glucagon-like peptide-1 (GLP-1) medications have emerged as powerful tools for weight loss. So far, injectable options ...

Users of the weight-loss injection Wegovy have said they will not be swapping to the pill form of the drug, which is now ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Weight loss can be a challenge, even for those who eat healthily and exercise regularly. Injectable weight loss medications — also ...

Novo Nordisk and Vivani Medical are testing a small implant that releases semaglutide over several months, potentially ...

Phase 3 clinical trial results (TRANSCEND-T2D-1) published in The Lancet report that retatrutide, an investigational ...

Weight-loss injections like GLP-1 agonists aid diabetes and obesity but require thorough patient assessment before prescription.

For millions of people taking weight loss drugs, the next breakthrough may not be more weight loss. It may be fewer injections. Limited time: Save 25% on NBC News subscription Get exclusive reporting, ...

One simple thing could prevent people using the ‘miracle’ drugs from sustaining long-term health consequences.